{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:05:54Z","timestamp":1769101554840,"version":"3.49.0"},"reference-count":31,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100013263","name":"Norwegian Health association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013263","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Norwegian Health association"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,11,7]]},"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To estimate the number needed to screen (NNS) and the number needed to treat (NNT) to prevent one tuberculosis (TB) case in the Norwegian immigrant latent tuberculosis infection (LTBI) screening programme and to explore the effect of delay of LTBI treatment initiation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Population-based, prospective cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Immigrants to Norway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcome<\/jats:title><jats:p>Incident TB.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We obtained aggregated data on immigration to Norway in 2008\u20132011 and used data from the Norwegian Surveillance System for Infectious Diseases to assess the number of TB cases arising in this cohort within 5 years after arrival. We calculated the average NNS and NNT for immigrants from the top 10 source countries for TB in Norway and by estimated TB incidence rates in source countries. We explored the sensitivity of these estimates with regard to test performance, treatment efficacy and treatment adherence using an extreme value approach, and assessed the effects of emigration, time to TB diagnosis (to define incident TB) and intervention timing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>NNS and NNT were overall high, with substantial variation. NNT showed numerically stronger negative correlation with TB notification rate in Norway (\u22120.75 [95% CI \u22121.00 to \u22120.44]) than with the WHO incidence rate (IR) (\u22120.32 [95% CI \u22120.93 to 0.29]). NNT was affected substantially by emigration and the definition of incident TB. Estimates were lowest for Somali (NNS 99 [70\u2013150], NNT 27 [19\u201341]) and highest for Thai immigrants (NNS 585 [413\u2013887], NNT 111 [79\u2013116]). Implementing LTBI treatment in immigrants sooner after arrival may improve the effectiveness of the programme.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Using TB notifications in Norway, rather than IR in source countries, would improve targeting of immigrants for LTBI management. However, the overall high NNT is a concern and challenges the scale-up of preventive LTBI treatment for significant public health impact. Better data are urgently needed to monitor and evaluate NNS and NNT in countries implementing LTBI screening.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2018-023412","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T09:37:20Z","timestamp":1547804240000},"page":"e023412","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study"],"prefix":"10.1136","volume":"9","author":[{"given":"Brita Askeland","family":"Winje","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gry Marysol","family":"Gr\u00f8neng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Aubrey","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Akre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preben","family":"Aavitsland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einar","family":"Heldal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"2024051713490317000_9.1.e023412.1","unstructured":"WHO. Guidelines for the management of latent tuberculosis infection Geneva. 2014 http:\/\/www.who.int\/tb\/publications\/ltbi_document_page\/en\/."},{"key":"2024051713490317000_9.1.e023412.2","unstructured":"WHO. Latent TB Infection: Updated and consolidated guidelines for programmatic management. 2018. WHO\/CDS\/TB\/2018.4:74 http:\/\/www.who.int\/tb\/publications\/2018\/latent-tuberculosis-infection\/en\/."},{"key":"2024051713490317000_9.1.e023412.3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5588\/ijtld.17.0036","article-title":"Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results","volume":"21","author":"Kunst","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024051713490317000_9.1.e023412.4","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203254"},{"key":"2024051713490317000_9.1.e023412.5","unstructured":"Arnesen TM , Heldal E , Mengshoel AT , et al . Tuberkulose i Norge i 2016 med behandlingsresultater for 2015. Oslo: Folkehelseinstituttet, 2017."},{"key":"2024051713490317000_9.1.e023412.6","unstructured":"WHO. Global tuberculosis report. Geneva, Switzerland, 2014."},{"key":"2024051713490317000_9.1.e023412.7","unstructured":"Folkehelseinstituttet. Guidelines for prevention and control of tuberculosis. Oslo: Norwegian Institute of Public Health, 2016."},{"key":"2024051713490317000_9.1.e023412.8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-65"},{"key":"2024051713490317000_9.1.e023412.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-201542"},{"key":"2024051713490317000_9.1.e023412.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70069-X"},{"key":"2024051713490317000_9.1.e023412.11","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00034-13"},{"key":"2024051713490317000_9.1.e023412.12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2350"},{"key":"2024051713490317000_9.1.e023412.13","doi-asserted-by":"crossref","first-page":"419-28","DOI":"10.7326\/M14-1019","article-title":"Treatment of latent tuberculosis infection: a network meta-analysis","volume":"161","author":"Stagg","year":"2014","journal-title":"Ann Intern Med"},{"key":"2024051713490317000_9.1.e023412.14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01397-2015"},{"key":"2024051713490317000_9.1.e023412.15","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0692"},{"key":"2024051713490317000_9.1.e023412.16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5588\/pha.13.0011","article-title":"Management of latent tuberculous infection in Norway in 2009: a descriptive cross-sectional study","volume":"3","author":"Olsen","year":"2013","journal-title":"Public Health Action"},{"key":"2024051713490317000_9.1.e023412.17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12879-018-3468-z","article-title":"Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study","volume":"18","author":"Schein","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2024051713490317000_9.1.e023412.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806303182605"},{"key":"2024051713490317000_9.1.e023412.19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/1753-6405.12161","article-title":"Can Australia eliminate TB? Modelling immigration strategies for reaching MDG targets in a low-transmission setting","volume":"38","author":"Denholm","year":"2014","journal-title":"Aust N Z J Public Health"},{"key":"2024051713490317000_9.1.e023412.20","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr058"},{"key":"2024051713490317000_9.1.e023412.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70276-7"},{"key":"2024051713490317000_9.1.e023412.22","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268897007917"},{"key":"2024051713490317000_9.1.e023412.23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-3157"},{"key":"2024051713490317000_9.1.e023412.24","first-page":"1374","article-title":"Age-related risk of hepatotoxicity in the treatment of latent tuberculosis infection: a systematic review","volume":"14","author":"Kunst","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024051713490317000_9.1.e023412.25","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2013.0437"},{"key":"2024051713490317000_9.1.e023412.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00151-8"},{"key":"2024051713490317000_9.1.e023412.27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201308-1480OC","article-title":"Persistent latent tuberculosis reactivation risk in United States immigrants","volume":"189","author":"Walter","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2024051713490317000_9.1.e023412.28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4045\/tidsskr.11.0566","article-title":"Poor follow-up after screening for tuberculosis","volume":"132","author":"Harstad","year":"2012","journal-title":"TidsskrNor Laegeforen"},{"key":"2024051713490317000_9.1.e023412.29","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-10-670","article-title":"The role of entry screening in case finding of tuberculosis among asylum seekers in Norway","volume":"10","author":"Harstad","year":"2010","journal-title":"BMC Public Health"},{"key":"2024051713490317000_9.1.e023412.30","doi-asserted-by":"crossref","unstructured":"Winje BA , White R , Syre H , et al . Stratification by interferon-\u03b3 release assay level predicts risk of incident TB. Thorax 2018:652\u201361.doi:10.1136\/thoraxjnl-2017-211147","DOI":"10.1136\/thoraxjnl-2017-211147"},{"key":"2024051713490317000_9.1.e023412.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2738"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-023412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:41:27Z","timestamp":1715989287000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-023412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1136\/bmjopen-2018-023412"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-023412","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}